Pharmacology and the Nursing Process 11th Edition by Linda Lane Lilley PhD RN, Shelly
Rainforth Collins PharmD BCGP, Julie S. Snyder MSN RN MEDSURG-BC (2026) || LATEST
EDITION || GRANTEE PASS
11th Edition
,Table of Contents
Part 1: pharmacology basics .................................................................... 5
Chapter 01: the nursing process and drug therapy .................................................................... 5
Chapter 02: pharmacologic principles ...................................................................................... 11
Chapter 03: lifespan considerations ......................................................................................... 20
Chapter 04: cultural, legal, and ethical considerations ............................................................. 29
Chapter 05: medication errors: preventing and responding .................................................... 37
Chapter 06: patient education and drug therapy ..................................................................... 42
Chapter 07: over-the-counter drugs and herbal and dietary supplements.............................. 48
Chapter 08: gene therapy and pharmacogenomics.................................................................. 54
Chapter 09: photo atlas of drug administration ....................................................................... 59
Part 2: drugs affecting the central nervous system .............................. 71
Chapter 10: analgesic drugs ...................................................................................................... 71
Chapter 11: general and local anesthetics ................................................................................ 81
Chapter 12: central nervous system depressants and muscle relaxants .................................. 87
Chapter 13: central nervous system stimulants and related drugs .......................................... 94
Chapter 14: antiepileptic drugs............................................................................................... 100
Chapter 15: antiparkinson drugs ............................................................................................ 108
Chapter 16: psychotherapeutic drugs ..................................................................................... 115
Chapter 17: substance use disorder ....................................................................................... 125
Part 3: drugs affecting the autonomic nervous system ...................... 132
Chapter 18: adrenergic drugs ................................................................................................. 132
Chapter 19: adrenergic-blocking drugs ................................................................................... 139
Chapter 20: cholinergic drugs ................................................................................................. 146
Chapter 21: cholinergic-blocking drugs .................................................................................. 153
Part 4: drugs affecting the cardiovascular and renal systems ........... 159
Chapter 22: antihypertensive drugs........................................................................................ 159
Chapter 23: antianginal drugs ................................................................................................. 168
Chapter 24: heart failure drugs ............................................................................................... 176
, Chapter 25: antidysrhythmic drugs......................................................................................... 184
Chapter 26: coagulation modifier drugs ................................................................................. 192
Chapter 27: antilipemic drugs ................................................................................................. 200
Chapter 28: diuretic drugs ...................................................................................................... 207
Chapter 29: fluids and electrolytes ......................................................................................... 215
Part 5: drugs affecting the endocrine and reproductive systems ...... 223
Chapter 30: pituitary drugs ..................................................................................................... 223
Chapter 31: thyroid and antithyroid drugs ............................................................................. 228
Chapter 32: antidiabetic drugs................................................................................................ 234
Chapter 33: adrenal drugs ...................................................................................................... 246
Chapter 34: women’s health drugs ......................................................................................... 251
Chapter 35: men’s health drugs .............................................................................................. 261
Part 6: drugs affecting the respiratory system ................................... 267
Chapter 36: antihistamines, decongestants, antitussives, and expectorants ......................... 267
Chapter 37: respiratory drugs ................................................................................................. 274
Part 7: antiinfective and antiinflammatory drugs ................................ 282
Chapter 38: antibiotics part 1 ................................................................................................. 282
Chapter 39: antibiotics part 2 ................................................................................................. 292
Chapter 40: antiviral drugs ...................................................................................................... 299
Chapter 41: antitubercular drugs ............................................................................................ 306
chapter 42: antifungal drugs ................................................................................................... 311
Chapter 43: antimalarial, antiprotozoal, and anthelmintic drugs........................................... 318
Chapter 44: anti-inflammatory and antigout drugs ................................................................ 325
Part 8: chemotherapeutic drugs and biologic and immune modifiers ................................... 333
Chapter 45: antineoplastic drugs part 1: cancer overview and cell cycle-specific drugs ....... 334
Chapter 46: antineoplastic drugs part 2: cell cycle–nonspecific drugs and miscellaneous drugs
................................................................................................................................................. 341
Chapter 47: biologic response–modifying and antirheumatic drugs ..................................... 348
Chapter 48: immunosuppressant drugs ................................................................................. 355
, Chapter 49: immunizing drugs ................................................................................................ 362
Part 9: drugs affecting the gastrointestinal system and nutrition ..... 368
Chapter 50: acid-controlling drugs.......................................................................................... 368
Chapter 51: bowel disorder drugs .......................................................................................... 376
Chapter 52: antiemetic and antinausea drugs ........................................................................ 386
Chapter 53: vitamins and minerals ......................................................................................... 393
Chapter 54: anemia drugs ....................................................................................................... 400
Chapter 55: nutritional supplements ...................................................................................... 409
part 10: dermatologic, ophthalmic, and otic drugs ............................. 415
Chapter 56: dermatologic drugs ............................................................................................. 416
Chapter 57: ophthalmic drugs ................................................................................................ 424
Chapter 58: otic drugs ............................................................................................................. 431
,Part 1: pharmacology basics
Chapter 01: the nursing process and drug therapy
Multiple choice
1. The nurse is developing a human needs statement for a patient who has a new diagnosis
of heart failure. Identification of human needs statements occur with which of these activities?
A. Collection of patient data
B. Administering interventions
C. Deciding on patient outcomes
D. Documenting the patient’s behavior
Correct ans>>a
Identification of human needs occurs with the collection of patient data.
Dif: cognitive level: understanding (comprehension) top: nursing process: human needs
statement
Msc: nclex: safe and effective care environment: management of care
2. The patient is to receive oral guaifenesin (mucinex) twice a day. Today, the nurse was
busy and gave the medication 2 hours after the scheduled dose was due. What type of problem
does this represent?
A. “right time”
B. “right dose”
C. “right route”
D. “right medication”
Correct ans>>a
“right time” is correct because the medication was given more than 30 minutes after the
scheduled dose was due. “dose” is incorrect because the dose is not related to the time the
, medication administration is scheduled. “route” is incorrect because the route is not affected.
“medication” is incorrect because the medication ordered will not change.
Dif: cognitive level: applying (application) top: nursing process: implementation
Msc: nclex: safe and effective care environment: safety and infection control
3. The nurse has been monitoring the patient’s progress on a new drug regimen since the
first dose and documenting the patient’s therapeutic response to the medication. Which phase
of the nursing process do these actions illustrate?
A. Human needs statement
B. Planning
C. Implementation
D. Evaluation
Correct ans>>d
Monitoring the patient’s progress, including the patient’s response to the medication, is part of
the evaluation phase. Planning, implementation, and human needs statement are not
illustrated by this example.
Dif: cognitive level: understanding (comprehension) top: nursing process: evaluation
Msc: nclex: safe and effective care environment: management of care
4. The nurse is assigned to a patient who is newly diagnosed with type 1 diabetes mellitus.
Which statement best illustrates an outcome criterion for this patient?
A. The patient will follow instructions.
B. The patient will not experience complications.
C. The patient will adhere to the new insulin treatment regimen.
D. The patient will demonstrate correct blood glucose testing technique.
Correct ans>>d